REVB - Revelation Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

REVB is currently covered by 1 analysts with an average price target of $4.68. This is a potential upside of $2.3 (96.64%) from yesterday's end of day stock price of $2.38.

Revelation Biosciences's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of REVB is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 244 days.

Highest price target for REVB is $81, Lowest price target is $81, average price target is $4.68.

Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 14-Feb-2023. First documented stock forecast 17-Feb-2022.

Best performing analysts who are covering REVB - Revelation Biosciences:

Jonathan Aschoff

Currently out of the existing stock ratings of REVB, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5

$1.36 (37.36%)

12

1 years 2 months 24 days ago

3/3 (100%)

$2.3 (85.19%)

244

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is REVB (Revelation Biosciences) average time for price targets to be met?

On average it took 244 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on REVB (Revelation Biosciences) with a proven track record?

JONATHAN ASCHOFF

Which analyst has the most public recommendations on REVB (Revelation Biosciences)?

Jonathan Aschoff has 0 price targets and 3 ratings on REVB

Which analyst is the currently most bullish on REVB (Revelation Biosciences)?

Jonathan Aschoff with highest potential upside - $1.36

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?